Exelixis Inc at Bernstein Strategic Decisions Conference Transcript
Hi, my name is Jeffrey Walsh. I co-lead the US biotechnology coverage at Bernstein. Very excited today to have a nice fireside chat with Michael Morrissey, PhD, President, and Chief Executive Officer of Exalexis. Look forward to the conversation and thank you for attending.
All right, great to be here. Thanks for the invitation.
Today and looking forward to we had a great day, looking forward to a great conversation.
Before I begin, let me just state that I'll be making forward-looking statements today, so people listening should see our SEC filings for a description of the risks that we face in our business.
That's perfect. And Michael, really appreciate you and the team coming out today. We've had you attend multiple of these conferences and really appreciate always hearing your story. And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
